These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12891671)

  • 1. Minocycline and doxycycline are not beneficial in a model of Huntington's disease.
    Smith DL; Woodman B; Mahal A; Sathasivam K; Ghazi-Noori S; Lowden PA; Bates GP; Hockly E
    Ann Neurol; 2003 Aug; 54(2):186-96. PubMed ID: 12891671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.
    Stack EC; Smith KM; Ryu H; Cormier K; Chen M; Hagerty SW; Del Signore SJ; Cudkowicz ME; Friedlander RM; Ferrante RJ
    Biochim Biophys Acta; 2006 Mar; 1762(3):373-80. PubMed ID: 16364609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles.
    Smith DL; Portier R; Woodman B; Hockly E; Mahal A; Klunk WE; Li XJ; Wanker E; Murray KD; Bates GP
    Neurobiol Dis; 2001 Dec; 8(6):1017-26. PubMed ID: 11741397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of minocycline efficiency in genetic models of Huntington's disease.
    Mievis S; Levivier M; Communi D; Vassart G; Brotchi J; Ledent C; Blum D
    Neuromolecular Med; 2007; 9(1):47-54. PubMed ID: 17114824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
    Martín-Aparicio E; Yamamoto A; Hernández F; Hen R; Avila J; Lucas JJ
    J Neurosci; 2001 Nov; 21(22):8772-81. PubMed ID: 11698589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of Huntington's disease.
    Menalled LB; Chesselet MF
    Trends Pharmacol Sci; 2002 Jan; 23(1):32-9. PubMed ID: 11804649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
    Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
    Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington's Disease.
    Paldino E; Balducci C; La Vitola P; Artioli L; D'Angelo V; Giampà C; Artuso V; Forloni G; Fusco FR
    Mol Neurobiol; 2020 Apr; 57(4):1889-1903. PubMed ID: 31879858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintained improvement with minocycline of a patient with advanced Huntington's disease.
    Denovan-Wright EM; Devarajan S; Dursun SM; Robertson HA
    J Psychopharmacol; 2002 Dec; 16(4):393-4. PubMed ID: 12503842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
    Nguyen T; Hamby A; Massa SM
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11840-5. PubMed ID: 16087879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased hippocampal cell proliferation in R6/1 Huntington's mice.
    Lazic SE; Grote H; Armstrong RJ; Blakemore C; Hannan AJ; van Dellen A; Barker RA
    Neuroreport; 2004 Apr; 15(5):811-3. PubMed ID: 15073520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
    Milnerwood AJ; Cummings DM; Dallérac GM; Brown JY; Vatsavayai SC; Hirst MC; Rezaie P; Murphy KP
    Hum Mol Genet; 2006 May; 15(10):1690-703. PubMed ID: 16600988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline in phenotypic models of Huntington's disease.
    Bantubungi K; Jacquard C; Greco A; Pintor A; Chtarto A; Tai K; Galas MC; Tenenbaum L; Déglon N; Popoli P; Minghetti L; Brouillet E; Brotchi J; Levivier M; Schiffmann SN; Blum D
    Neurobiol Dis; 2005 Feb; 18(1):206-17. PubMed ID: 15649711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1.
    Sancho M; Herrera AE; Gortat A; Carbajo RJ; Pineda-Lucena A; Orzáez M; Pérez-Payá E
    Hum Mol Genet; 2011 Sep; 20(18):3545-53. PubMed ID: 21659333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
    Ransome MI; Hannan AJ
    Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
    Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
    Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
    Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
    Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease.
    Diguet E; Rouland R; Tison F
    Ann Neurol; 2003 Dec; 54(6):841-2. PubMed ID: 14681898
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease.
    van der Borght K; Brundin P
    Exp Neurol; 2007 Mar; 204(1):473-8. PubMed ID: 17187781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease.
    Kohl Z; Kandasamy M; Winner B; Aigner R; Gross C; Couillard-Despres S; Bogdahn U; Aigner L; Winkler J
    Brain Res; 2007 Jun; 1155():24-33. PubMed ID: 17512917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.